Vanguard Capital Management’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.4M Buy
3,513,193
+171,976
+5% +$1.87M ﹤0.01% 2174
2026
Q2
$41.8M Buy
3,341,217
+257,700
+8% +$3.45M ﹤0.01% 2048
2026
Q1
$46M Buy
+3,083,517
New +$68.6M ﹤0.01% 1894

Other funds holding OLMA

Vanguard Capital Management's OLMA Position: Q3 2026 in Review

Vanguard Capital Management increased its Olema Oncology (OLMA) stake by 5.1% in Q3 2026, buying an estimated $1.87M and bringing the position to 3,513,193 shares worth $30.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

Vanguard Capital Management first reported a position in OLMA in Q1 2026 and has held it in 3 quarters since. The position peaked at $46M in Q1 2026. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Vanguard Capital Management held 3,513,193 shares of Olema Oncology worth $30.4M as of Q3 2026.
  • Vanguard Capital Management bought 171,976 Olema Oncology shares in Q3 2026, an estimated $1.87M.
  • Olema Oncology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2174 holding.
  • Vanguard Capital Management first reported a position in Olema Oncology in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Olema Oncology position peaked at $46M in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.